Wall Street Journal14d
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
Eli Lilly has finally made ... drug was introduced with the brand Mounjaro for diabetes. Tirzepatide was approved as Zepbound in late 2023 as a weight-loss treatment.
Daily Reporter14d
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
MarketWatch15d
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in ...
The i on MSN7h
Mounjaro v Ozempic: Inside the race to reveal the best weight-loss jab
A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...